Health care pharmaceutical companies by short interest
Shares sold short and not yet covered, as reported to FINRA for the latest settlement date, as a percent of shares outstanding (market value divided by share price), not of the smaller float.
TG Therapeutics leads the 61 health care pharmaceutical companies ranked by short interest, at 19.0%, ahead of Rhythm Pharmaceuticals (16.8%) and Dianthus Therapeutics (16.5%). Figures as of the 30 Oct 2026 settlement date, from FINRA's short interest report, with shares outstanding from Yahoo Finance quotes.
Key facts
- Companies ranked
- 61
- First
- TG Therapeutics19.0%
- Median
- 5.47%
- Combined market value
- NOK 48.47T
- Countries
- 10
Market values as of .
All countries▾
Health Care▾
Pharmaceuticals▾
| # | Company | Short interest % ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | TG TherapeuticsTGTX · Health Care | 19.0% | NOK 95.8B | NOK 633.70 | 1.88% down | 117% up | ||
| 2 | Rhythm PharmaceuticalsRYTM · Health Care | 16.8% | NOK 79.1B | NOK 1,140.81 | 1.88% down | 18% up | ||
| 3 | Dianthus TherapeuticsDNTH · Health Care | 16.5% | NOK 46.7B | NOK 828.55 | 1.01% up | 108% up | ||
| 4 | Protagonist TherapeuticsPTGX · Health Care | 15.7% | NOK 79.1B | NOK 1,211.33 | 2.47% down | 51% up | ||
| 5 | Praxis Precision MedicinesPRAX · Health Care | 15.1% | NOK 84.9B | NOK 3,036.63 | 1.87% up | 86% up | ||
| 6 | CytokineticsCYTK · Health Care | 12.9% | NOK 70B | NOK 502.62 | 0.27% up | 19% down | ||
| 7 | Ionis PharmaceuticalsIONS · Health Care | 12.7% | NOK 44.3B | NOK 265.86 | 0.62% down | 63% down | ||
| 8 | Ligand PharmaceuticalsLGND · Health Care | 12.3% | NOK 56.1B | NOK 2,802.61 | 3.94% down | 50% up | ||
| 9 | Spyre TherapeuticsSYRE · Health Care | 12.2% | NOK 90.6B | NOK 953.57 | 3.77% down | 332% up | ||
| 10 | AlkermesALKS · Health Care | 11.7% | NOK 75.8B | NOK 451.05 | 1.43% down | 66% up | ||
| 11 | Edgewise TherapeuticsEWTX · Health Care | 11.6% | NOK 44B | NOK 402.12 | 0.48% down | 86% up | ||
| 12 | BridgeBio PharmaBBIO · Health Care | 10.7% | NOK 148.8B | NOK 763.60 | 0.22% up | 21% up | ||
| 13 | ErascaERAS · Health Care | 10.6% | NOK 48.7B | NOK 138.89 | 3.34% up | 395% up | ||
| 14 | Cogent BiosciencesCOGT · Health Care | 10.0% | NOK 47.1B | NOK 270.94 | 0.25% down | 20% down | ||
| 15 | Mirum PharmaceuticalsMIRM · Health Care | 9.99% | NOK 60.9B | NOK 932.87 | 3.27% up | 34% up | ||
| 16 | Travere TherapeuticsTVTX · Health Care | 9.96% | NOK 45.3B | NOK 471.76 | 3.86% down | 45% up | ||
| 17 | Oruka TherapeuticsORKA · Health Care | 9.53% | NOK 64.6B | NOK 952.99 | 1.91% up | 255% up | ||
| 18 | PTC TherapeuticsPTCT · Health Care | 9.31% | NOK 47.6B | NOK 569.67 | 3.16% down | 21% down | ||
| 19 | Madrigal PharmaceuticalsMDGL · Health Care | 9.20% | NOK 90B | NOK 3,875.05 | 0.34% down | 27% down | ||
| 20 | Jazz PharmaceuticalsJAZZ · Health Care | 9.03% | NOK 148.2B | NOK 2,309.46 | 4.57% down | 41% up | ||
| 21 | Corcept TherapeuticsCORT · Health Care | 8.34% | NOK 69.5B | NOK 634.67 | 4.15% down | 10% down | ||
| 22 | Arrowhead PharmaceuticalsARWR · Health Care | 8.19% | NOK 60.3B | NOK 426.34 | 1.25% up | 13% up | ||
| 23 | VeradermicsMANE · Health Care | 8.03% | NOK 51.3B | NOK 1,214.95 | 0.38% down | 231% up | ||
| 24 | BioMarin PharmaceuticalBMRN · Health Care | 7.29% | NOK 116.2B | NOK 599.90 | 0.02% down | 17% up | ||
| 25 | Definium TherapeuticsDFTX · Health Care | 7.02% | NOK 39.4B | NOK 287.94 | 1.24% up | 168% up | ||
| 26 | Elanco Animal HealthELAN · Health Care | 6.59% | NOK 128.3B | NOK 256.78 | 1.54% down | 26% up | ||
| 27 | InsmedINSM · Health Care | 6.42% | NOK 309.5B | NOK 1,410.97 | 20.58% up | 40% down | ||
| 28 | Roivant SciencesROIV · Health Care | 6.28% | NOK 275.7B | NOK 380.53 | 0.59% up | 91% up | ||
| 29 | Axsome TherapeuticsAXSM · Health Care | 6.20% | NOK 69.7B | NOK 1,325.22 | 1.25% up | 6% down | ||
| 30 | Legend BiotechLEGN · Health Care | 6.13% | NOK 30.5B | NOK 157.25 | 0.92% down | 41% down | ||
| 31 | Kiniksa Pharmaceuticals InternationalKNSA · Health Care | 5.47% | NOK 71.8B | NOK 913.58 | 1.59% down | 129% up | ||
| 32 | Summit TherapeuticsSMMT · Health Care | 5.28% | NOK 82.6B | NOK 103.24 | 0.67% up | 36% down | ||
| 33 | ABIVAXABVX · Health Care | 4.70% | NOK 69B | NOK 787.73 | 3.79% down | 32% down | ||
| 34 | Ascendis PharmaASND · Health Care | 4.57% | NOK 164B | NOK 2,500.02 | 5.32% down | 29% up | ||
| 35 | United TherapeuticsUTHR · Health Care | 4.31% | NOK 232.6B | NOK 5,460.86 | 3.16% down | 22% up | ||
| 36 | ZoetisZTS · Health Care | 4.12% | NOK 320.6B | NOK 789.09 | 5.59% down | 26% down | ||
| 37 | Alnylam PharmaceuticalsALNY · Health Care | 4.08% | NOK 193.4B | NOK 1,443.79 | 1.06% down | 66% down | ||
| 38 | Belite BioBLTE · Health Care | 3.40% | NOK 59.9B | NOK 1,475.05 | 3.33% down | 43% up | ||
| 39 | Amneal PharmaceuticalsAMRX · Health Care | 3.27% | NOK 72.8B | NOK 208.92 | 2.24% down | 90% up | ||
| 40 | ViatrisVTRS · Health Care | 3.07% | NOK 222.6B | NOK 194.17 | 1.97% down | 99% up | ||
| 41 | Dr. Reddy's LaboratoriesRDY · Health Care | 3.03% | NOK 120.8B | NOK 144.85 | 1.00% down | 8% up | ||
| 42 | Teva Pharmaceutical IndustriesTEVA · Health Care | 2.38% | NOK 439.2B | NOK 376.43 | 8.74% down | 74% up | ||
| 43 | PfizerPFE · Health Care | 2.36% | NOK 1.53T | NOK 268.99 | 1.85% down | 15% up | ||
| 44 | Bristol-Myers SquibbBMY · Health Care | 2.29% | NOK 1.16T | NOK 569.82 | 2.05% down | 30% up | ||
| 45 | Royalty PharmaRPRX · Health Care | 2.27% | NOK 380.3B | NOK 661.44 | 1.38% down | 79% up | ||
| 46 | Regeneron PharmaceuticalsREGN · Health Care | 2.14% | NOK 932.9B | NOK 9,018.47 | 2.35% down | 28% up | ||
| 47 | Vertex PharmaceuticalsVRTX · Health Care | 1.90% | NOK 1.29T | NOK 5,085.41 | 2.94% down | 27% up | ||
| 48 | GenmabGMAB · Health Care | 1.57% | NOK 309.3B | NOK 501.55 | 0.75% up | 70% up | ||
| 49 | BeOne MedicinesONC · Health Care | 1.40% | NOK 445.9B | NOK 3,903.96 | 0.97% down | 16% up | ||
| 50 | Abbott LaboratoriesABT · Health Care | 1.10% | NOK 1.76T | NOK 1,014.52 | 0.58% down | 16% down | ||
| 51 | Merck & CoMRK · Health Care | 1.08% | NOK 3.2T | NOK 1,297.19 | 3.61% down | 45% up | ||
| 52 | AbbVieABBV · Health Care | 0.89% | NOK 4.9T | NOK 2,769.40 | 0.86% down | 25% up | ||
| 53 | GrifolsGRFS · Health Care | 0.88% | NOK 54.5B | NOK 80.09 | 3.19% down | 0% up | ||
| 54 | Novo NordiskNVO · Health Care | 0.87% | NOK 1.67T | NOK 379.65 | 1.42% down | 17% down | ||
| 55 | Eli LillyLLY · Health Care | 0.81% | NOK 11.75T | NOK 13,196.70 | 2.29% down | 33% up | ||
| 56 | GSKGSK · Health Care | 0.81% | NOK 936.2B | NOK 467.07 | 1.56% down | 5% up | ||
| 57 | Johnson & JohnsonJNJ · Health Care | 0.71% | NOK 6.28T | NOK 2,609.22 | 2.04% down | 34% up | ||
| 58 | SanofiSNY · Health Care | 0.51% | NOK 1.08T | NOK 449.88 | 2.25% down | 4% down | ||
| 59 | NovartisNVS · Health Care | 0.24% | NOK 2.79T | NOK 1,477.00 | 2.57% down | 25% up | ||
| 60 | AstraZenecaAZN · Health Care | 0.20% | NOK 2.66T | NOK 1,713.27 | 1.87% down | 1% up | ||
| 61 | Takeda PharmaceuticalTAK · Health Care | 0.10% | NOK 668.1B | NOK 209.12 | 0.66% up | 51% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; short interest from FINRA, the owner and source of the data, as of the 30 Oct 2026 settlement date.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Source: FINRA. Short interest is the shares sold short and not yet covered as brokers reported them to FINRA for the 30 Oct 2026 settlement date; FINRA publishes it about seven business days later, so it is not today's figure. It is divided by shares outstanding worked out as the market value over the share price, both from the same quote — not by the float, so the percent reads lower than a percent of float would. For a company with more than one class of shares the market value covers every class, which lowers it further. Sums are converted from US dollars at today's exchange rate (1 USD = 9.7672 NOK).
Questions and answers
Which health care pharmaceutical companies rank first by short interest?
TG Therapeutics (19.0%), Rhythm Pharmaceuticals (16.8%) and Dianthus Therapeutics (16.5%) are the top three of the 61 health care pharmaceutical companies ranked by short interest as of the 30 Oct 2026 settlement date.
How many health care pharmaceutical companies are in this ranking?
61 are ranked by short interest.
What are these health care pharmaceutical companies worth together?
The 61 health care pharmaceutical companies ranked by short interest have a combined market value of NOK 48.47T as of the 30 Oct 2026 settlement date.
What does ranking by short interest measure?
Shares sold short and not yet covered, as reported to FINRA for the latest settlement date, as a percent of shares outstanding (market value divided by share price), not of the smaller float.
Learn how this ranking works
All markets guides →- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
- How companies are sorted into sectors and industries
Companies are sorted into sectors and industries by classification systems. The index providers MSCI and S&P Dow Jones Indices use GICS: 11 sectors split into 25 industry groups, 74 industries and 163 sub-industries. SEC filings carry a four-digit SIC code. The two can place one company differently, because each looks at the business from its own angle.
- Market cap vs enterprise value: what is the difference?
Market capitalization is the value of a company's shares. Enterprise value is market cap plus debt, minus cash: roughly what it would cost to buy the whole business and settle its borrowings. Two companies with the same $50 billion market cap can have very different enterprise values if one owes $20 billion and the other holds $20 billion in cash.
Cite this page
Funkfolio, “Health care pharmaceutical companies by short interest”, data as of 19 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?sector=health-care&by=short-interest
Underlying data: FINRA short interest (the 30 Oct 2026 settlement date); Yahoo Finance.